


BADQOMOCAWGOWLD
NASDAQ:ACON Aclarion Inc Target PTs 6 --> 16 and higher Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw...
$TSUKA Dejitaru Tsuka ($TSUKA Dex) (Tax Modifiable) (MARKET CAP $30.21M) Target PTs .25 --> .03580 --> .399 --> .047 --> .22 --> .06 Tsuka is a decentralized community that is centered around meditation, reflection, and research. Tsuka encourages positive community sentiment through the study of philosophical, meditative, and spiritual ideas. The developer of...
NASDAQ:FUND Unification (MARKET CAP $3.84M) entry PTs .079 - .1027 (Buy date: 03 Apr '24 - 18 May '25) - Scale in PTs 1.35 - 2.98 and higher Timeline: Fall 2025 A Public/Private Blockchain ecosystem that allows deployment of Workchains. Workchains replace “DAPPS” and are operated independently from the Mainchain with a fixed UND price.. This allows predictable...
NASDAQ:AQB AquaBounty Technologies Inc entry PT 2.20-ish Target PTs 6 --> 8.20 --> 12.70 - 23 and higher AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. It engages in genetic, genomic, and fish health and nutrition research activities. The company...
NASDAQ:GVP GSE Systems, Inc. Target PTs 5.20 --> 3.22 --> 8.20 --> 11.30 and higher GSE Systems, Inc. provides professional and technical engineering services, staffing services, and simulation software to power and process industries in the United States, Asia, Europe, and internationally. It operates in two segments, Engineering and Workforce Solutions. The...
NASDAQ:FBIO Fortress Biotech Inc Target PTs 5.25 --> 10 --> 12.70 --> 17 and higher Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino an oral minocycline drug for the treatment of moderate to severe acne; Targadox an oral doxycycline...
NASDAQ:PRPO Precipio Inc Target PTs 11 --> 6.20 --> 14.80 and higher Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic...
NASDAQ:CING Cingulate Inc Target PT 33 and higher Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine)...
NYSE:FATH Fathom Digital Manufacturing Corporation Target PT 18 and higher Fathom Digital Manufacturing Corporation, a digital manufacturing platform, provides product development and manufacturing services in North America. It provides plastic and metal additive manufacturing, computer numerical control machining, injection molding and tooling, precision sheet...
NASDAQ:FAMI Farmmi Inc entry PT 1.10-ish Target PTs 4 --> 8.60 and higher Farmmi, Inc., together with its subsidiaries, processes and sells agricultural products in China, the United States, Japan, Canada, Europe, Korea, and the Middle East. The company offers shiitake and Mu Er mushrooms; and other edible fungi products, including bamboo fungi, agrocybe...
NASDAQ:HUBC Hub Cyber Security Ltd entry 2.08-ish Target PTs 4.30 --> 9 and higher HUB Cyber Security Ltd. provides cyber security solutions in Israel and internationally. The company offers HUB Secure File Vault, a super charged managed file transfer backed by dedicated hardware driven security, which creates a secure enclave to protect the organization's data...
NASDAQ:PIXY ShiftPixy Inc entry PTs 4.79 - 5-ish Target PTs 15 --> 29 --> 49 and higher ShiftPixy, Inc., together with its subsidiaries, provides staffing solutions in the United States. It offers employment administrative services, such as payroll processing, human resources consulting, and workers' compensation administration and coverage. The company operates...
NASDAQ:ADXN Addex Therapeutics Ltd ADR entry PT 5 Target PTs 9 --> 12 --> 20 and higher Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled...
NASDAQ:SAVA Cassava Sciences Inc Long term PT 145 and higher Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a...
NASDAQ:PLUG Plug Power Inc Long term PTs 75 - 105 and higher Plug Power Inc. delivers end-to-end clean hydrogen and zero-emissions fuel cell solutions for supply chain and logistics applications, on-road electric vehicles, stationary power market, and others in North America and internationally. It engages in building an end-to-end green hydrogen ecosystem,...
NASDAQ:OCGN Ocugen Inc Long term PTs 16 - 21 - 180 and higher Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited...
NASDAQ:NVAX Novavax, Inc. Long term PT 360 and higher Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to...
NASDAQ:FCEL Fuelcell Energy Inc Long term PTs 39 - 682 and higher FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell and electrolysis platforms that decarbonize power and produce hydrogen. The company provides various configurations and applications of its platform, including on-site power, utility grid support,...